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Abstract
Aims: Illicit cocaine consumption in Spain is one of the highest in Europe. Our objective was to
study the incidence of undisclosed cocaine consumption in patients attending in two Spanish
Emergency Departments for chest pain.
Methods: We analysed urine samples from consenting consecutive patients attending ED for chest
pain to determine the presence of cocaine, and other drugs, by semiquantative tests with
fluorescence polarization immunoassay (FPIA).
Results: Of 140 cases, 15.7 presented positive test for drugs, and cocaine was present in 6.4%. All
cocaine-positive patients were younger (p < 0.001); none was admitted to Hospital (p = 0.08). No
significant differences in ED stay or need for hospitalization were found between cocaine-positive
and negative patients.
Conclusion: This finding in chest pain patients who consented to urine analysis suggests that the
true incidence of cocaine use leading to such ED visits may be higher.
Introduction
Illicit cocaine consumption in Spain is, together with the
United Kingdom, the highest in Europe, mainly in young
people [1,2].
The relationship between cocaine use and episodes of cor-
onary ischemia or chest pain is clear, and cocaine is con-
sidered a new risk factor for cardiovascular events in
chronic users [3-5].
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To our knowledge, few studies have been performed in
Spain on the prevalence of cocaine consumption in
patients seeking Emergency Department attention when
this was not the direct reason for the visit [6,7].
The objective of this work was to study the incidence of
undisclosed cocaine consumption in patients attending
the Emergency Department (ED) of two hospitals for
chest pain.
Patients and methods
Between May and June 2006, we prospectively studied
urine samples from consecutive patients over 18 years
who were attended at two University Hospitals Emergency
Departments (Tenerife, Canary Islands and Barcelona,
Catalonia) for non-traumatic chest pain of probable car-
diovascular origin, initially not-related with cocaine con-
sumption.
Barcelona Hospital Clinic is a large, inner city, university
tertiary-care hospital, with a specialised Chest Pain Unit
within its ED. All Barcelona patients included in this study
were ED patients with chest pain attended by this unit.
The University Hospital of the Canary Islands (HUC) is a
large, suburban, university tertiary-care hospital, whose
ED has a special circuit for the attention of chest pain
patients, with similar features to the Barcelona chest pain
unit. All Tenerife patients included in this study were ED
patients with chest pain who were attended on this circuit.
Informed consent for urianalysis and participation in this
study was obtained from all participants. Urine samples
were stored at -80°C for subsequent analysis. Attending
physicians had no information of drugs test results.
The following variables were studied: age, sex, outcome
(death, hospital admission, discharge from ED), duration
of ED stay for non-admissions, days of hospital stay and
positive drugs test.
We measured in urine samples the levels of cocaine (ben-
zoylecgonine and methylecgonine ether), cannabis
(delta-9-tetrahidrocannabinol), amphetamine/metaam-
phetamine, opioids (morphine, and N-morphine). Drug
detection was performed by semiquantative tests with flu-
orescence polarization immunoassay (FPIA)(AxSYM Sys-
tem, Abbott laboratories, Illinois, USA.). We considered
the following values as positive: cocaine > 300 ng/ml, can-
nabis > 50 ng/ml, opioids > 300 ng/ml and ampheta-
mine/metaamphetamine > 1000 ng/ml.
Polyconsumption was defined as the presence of two or
more drugs in the samples analyzed.
The project was approved by the local ethical research
committee.
Statistical analysis
Results for categorical variables are expressed as frequen-
cies and percentages and 95% confidence intervals.
Results for numerical and ordinal variables are expressed
as means and standard deviations. Proportions were com-
pared with Chi-square test or Fisher's exact test whenever
required. Ranks between groups were compared with
Mann-Whitney U test or Wilcoxon-Mann-Whitney test
whenever required. A P value of less than 0.05 was consid-
ered to indicate statistical significance.
Statistical analysis was carried out with SPSS v. 14.0.1
(Chicago, ILL) and StatXact 5.0 (Cytel Co., Cambridge,
MA).
Results
Of 190 recorded patients, 140 agreed to participate in the
study and complete information was obtained. There was
some drug consumption in 15.7% (95% confidence inter-
val: 9.6%–21.7%) and 6.4% (95% confidence interval:
2.0%–10.4%) showed cocaine-positive test. Polycon-
sumption was present in 4.3% of patients. Demographic
features, ED management, and drug test results are shown
in Table 1. There were differences between the two Hospi-
tals in age, sex, hospital stay, cannabis consumption and
polyconsumption.
We found an inverse relation between cocaine consump-
tion and Hospital admission. One in two cocaine users
also used cannabis. No differences were observed between
cocaine users and non users regarding the concomitant
use of opiods and amphetamines (Table 2). We found an
association between cocaine and polyconsumption (p <
0.001).
Not unexpectedly, all cocaine-positive patients were
young men, ranging in age from 22 to 34 years. With
respect to follow-up data, all cocaine-positive patients
were discharged home from ED after attention
Discussion
In USA, with similar cocaine consumption rates to Spain,
the Drug Abuse Warning Network DAWN estimates that
cocaine was involved in 10% of drug misuse/abuse ED
visits [8,9]. In the study of Hollander et al prevalence of
cocaine use in chest pain of possible ischemic origin was
17%, ranged from 20% in Urban Hospitals ED to 7.45%
in Suburban Hospital EDs [10].
With respect to other Spanish studies, our finding of 6.4%
cocaine-positive chest pain patients was lower than the
25% reported by Sanjurjo et al [6,7]. This could be due to
features of our study population who were patients with
undisclosed cocaine-related chest pain, when in other
series the patient visit was related with declared consump-Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:11 http://www.sjtrem.com/content/17/1/11
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tion or clinical toxic cocaine-related signs suggestive of
consumption. As Perrone et al propose, drug screening for
substance abuse in addition to clinical history is necessary
for optimal identification of drug use in ED patients [11].
Our findings of low incidence of occult users added to
those of other series in declared or suspected cases may
provide a more realistic picture of cocaine consumption
in these ED patients in Spain. According to the literature,
it seems probable that the real incidence of cocaine use in
non-traumatic chest pain patients is around 30% [6,7,10].
As in other studies, the great majority of our cocaine-con-
suming patients with chest pain were young people, in
their third decade of life, and in general presumably at low
risk of adverse cardiovascular events [10,12,13]. Thus
none of them required admission to hospital. However,
caution must be exercised when evaluating these patients
with chest pain since there are no reliable tests to predict
adverse cardiovascular outcomes in cocaine-associated
chest pain [14].
The presence of cocaine in urine does not necessarily
imply that this substance was the cause of the chest pain
leading to their ED visit. Although urianalysis is usually
positive in the first 48–72 hours alter consumption,
chronic users can have positive urines for up to 2 weeks
[15]. Our data on the prevalence of cocaine use in young
people suggest that ED staff should be alert to possible
consumption that is not disclosed by the patient. Junior
doctors are less likely to routinely ask about cocaine use
compared to other classical risk factors [5,16].
Despite the fact that we studied two demographically dis-
parate groups of patients, we found no significant differ-
ences in clinical characteristics such as ED stay, need for
hospitalization or length of hospital stay. Nor did we find
differences in cocaine consumption between the two
groups, but this could very well be explained by the small
sample size. The high mean age of the Barcelona Hospital
group probably accounts for the low number of cocaine-
positive patients. In addition, this group was attended at
Table 1: Demographic, ED Management and drug results by Hospital.
Total
n = 140
Tenerife Hospital
N = 40
Barcelona Hospital
n = 100
P value
Age (years) 58.76 ± 19.3 49 ± 15.6 63 ± 19.3 < 0.001
Male sex – no (%) 90 (65) [57–73] 32 (80) [67.6–92.4] 58 (59) [49–68] 0.019
Emergency Dept. stay (hours) 4.43 ± 6.1 4.56 ± 7.67 4.3 ± 4.93 0.99
Hospital admission – no (%) 55 (40) [32–49] 21 (53) [37–68] 34 (35) [26–45] 0.08
Hospital stay (days) 7.1 ± 6.5 5.9 ± 7.2 8.5 ± 5.3 0.01
Cocaine
(positive test) – no (%)
9 (6) [2–10] 5 (12.5) [2.3–22.7] 4 (4) [1–8] 0.12
Cannabinoids
(positive test) – no (%)
9 (6) [2–10] 6 (15) [3.9–26.1] 3 (3) [0–6] 0.016
Opioids
(positive test) – no (%)
9 (6) [2–10] 2 (5) [0–11.7] 7 (7) [2–12] 0.5
Amphetamines
(positive test) – no (%)
1 (1) [0–2] 0 (0) [0-0] 1 (0) [0-0] 0.99
Any drug consumption – no (%) 22 (15.7) [1–22] 9 (22.5) [9.6–35.4] 13 (13) [6–20] 0.099
Polyconsumption – no (%) 6 (4.2) [0.1–8] 6 (15) [3.9–26.1] 0 (0) [0-0] < 0.001
Table 2: Demographics, ED management and other drug consumption in cocaine-positive/negative patients.
Total
n = 140
Cocaine-positive Patients
n = 9
Cocaine-negative Patients
n = 131
P value
Age (years) 58.76 ± 19.3 27.89 ± 5.77 60.89 ± 18.04 0.046
Male sex – no (%) 90 (65) [55–74] 9 (100) [100-100] 81 (62) [54–70] 0.017
ED stay (hrs) 4.43 ± 6.1 7.2 ± 2.3 4.13 ± 8.16 0.046
Hospitalization – no (%) 55 (40) [31–50] 0 (0) [0-0] 55 (42) [34–50] 0.008
Hospital stay (days) 7.1 ± 6.5 0 ± 0 7.6 ± 6.4 0.046
Cannabinoids
(positive test) – no (%)
9 (6) [2–11] 5 (55.6) [23.1–88.1] 4 (3) [0–6] < 0.001
Opioids
(positive test) – no (%)
9 (6) [2–11] 0 (0) [0-0] 9 (7) [3–11] 0.54
Amphetamines
(positive test) – no (%)
1 (0.7) [0–2] 1 (11.1) [0–31.6] 0 (0) [0-0] 0.99
Polyconsumption – no (%) 6 (4) [0–8] 6 (66.7) [35.1–96.9] 0 (0) [0-0] < 0.001Publish with BioMed Central    and   every 
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the Chest Pain Unit, without any fast-track circuit patients
(mostly young), as in previous studies by this group
[6,7,17].
Further research with longer study periods and greater
number of patients are required to confirm these findings.
Conclusion
This study found undisclosed cocaine consumption in
6.4% (95% confidence interval: 2.0%–10.4%) of adult
patients presenting at Emergency Department for chest
pain. This finding in chest pain patients who consented to
urine analysis suggests that the true incidence of cocaine
use leading to such ED visits may be higher.
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